Prospector Partners LLC Makes New $4.18 Million Investment in Option Care Health, Inc. $OPCH
Prospector Partners LLC recently invested $4.18 million in Option Care Health, acquiring 150,440 shares, making it a new 0.09% stake in the company. Institutional investors hold a significant 98.05% of Option Care Health's stock, and several analysts have recently upgraded their ratings and price targets for the company, with a consensus of "Moderate Buy" and an average target of $37.58. Option Care Health specializes in home and alternate site infusion services in the U.S.
How Option Care Health Inc. (OPCH) Affects Rotational Strategy Timing
This article analyzes Option Care Health Inc. (OPCH) through AI models, finding a neutral near-term sentiment and highlighting a breakout underway. It provides detailed trading strategies (Long, Momentum Breakout, Risk Hedging) with entry points, targets, and stop losses. The analysis also includes multi-timeframe signal analysis, support, and resistance levels for various time horizons.
Illinois Municipal Retirement Fund Raises Holdings in Option Care Health, Inc. $OPCH
The Illinois Municipal Retirement Fund significantly increased its stake in Option Care Health (NASDAQ:OPCH) by 48.5% in the third quarter, now owning 123,574 shares valued at $3.43 million. Several other institutional investors also adjusted their positions, with 98.05% of the stock owned by institutional investors and hedge funds. Analysts maintain a "Moderate Buy" rating for OPCH, with a consensus target price of $37.46, following multiple price target increases.
Option Care Health, Inc.'s (NASDAQ:OPCH) Stock Is Going Strong: Is the Market Following Fundamentals?
Option Care Health's stock has seen a significant 25% rise over the last three months, prompting an examination of its financial health. The company boasts an impressive Return on Equity (ROE) of 15%, which is higher than the industry average, and has demonstrated strong net income growth of 29% over the past five years by reinvesting all profits. While the company's performance is strong, analyst forecasts predict a slowdown in future earnings growth.
OPCH Stock Price, Forecast & Analysis | OPTION CARE HEALTH INC (NASDAQ:OPCH)
This article provides an analysis of OPTION CARE HEALTH INC (OPCH) stock, detailing its current price, technical and fundamental ratings, and market performance. It includes key statistics, financial highlights, analyst forecasts predicting a 14.67% price increase, and information about its competitors and company profile.
New York State Common Retirement Fund Reduces Holdings in Option Care Health, Inc. $OPCH
The New York State Common Retirement Fund significantly reduced its stake in Option Care Health (NASDAQ:OPCH) by 74.6% in the third quarter, selling 160,143 shares and retaining 54,491 shares valued at $1.513 million. Despite this reduction, institutional ownership in Option Care Health remains high at 98.05%, with other funds increasing or initiating positions. The company has a market capitalization of $5.27 billion, a PE ratio of 26.33, and a consensus "Moderate Buy" rating from analysts with an average price target of $37.46.
Profit Therapy: 3 Medical Stocks Ready to Deliver Q4 Beat
The article identifies three medical stocks — Tenet Healthcare Corporation (THC), Universal Health Services, Inc. (UHS), and Option Care Health, Inc. (OPCH) — that are poised to exceed fourth-quarter earnings expectations. These companies are benefiting from strengthened outpatient volumes, higher admissions, and the adoption of tech-enabled services, despite challenges like rising medical costs and wage inflation. The selections are based on a proprietary methodology combining a positive Earnings ESP and favorable Zacks Rank.
Option Care Health to Participate in the TD Cowen Healthcare Conference
Option Care Health, Inc. (Nasdaq: OPCH) announced its participation in the 46th Annual TD Cowen Healthcare Conference in Boston, MA, on Tuesday, March 3, 2026. The company, which is the largest independent provider of home and alternate site infusion services, will host a fireside chat at 1:10 PM ET. A webcast of the event will be accessible online for interested investors and stakeholders.
Option Care Health to Participate in the TD Cowen Healthcare Conference
Option Care Health, Inc. announced its participation in the 46th Annual TD Cowen Healthcare Conference in Boston, MA, on March 3, 2026. The company, the largest independent provider of home and alternate site infusion services, will host a fireside chat at 1:10 PM ET, with the webcast available online for investors.
Option Care Health to Participate in the TD Cowen Healthcare Conference
Option Care Health, Inc. (Nasdaq: OPCH) announced its participation in the 46th Annual TD Cowen Healthcare Conference on Tuesday, March 3, 2026, in Boston, MA. The company, which is the nation's largest independent provider of home and alternate site infusion services, will host a fireside chat at 1:10 PM ET, with a webcast available online for investors. This event provides an opportunity for the company to share updates on its operations and strategic vision.
Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by Analysts
Option Care Health, Inc. (NASDAQ:OPCH) has received a "Moderate Buy" consensus recommendation from analysts, with an average 12-month price target of $37.46. Insider, Director Harry M. Jansen Kraemer Jr., recently purchased 38,000 shares, increasing his stake by 10.12%. Institutional investors own a significant 98.05% of the company, with notable increases in holdings from firms like Durable Capital and Jennison Associates.
What You Can Learn From Option Care Health, Inc.'s (NASDAQ:OPCH) P/E
Option Care Health, Inc. (NASDAQ:OPCH) currently has a P/E ratio of 26.8x, which is higher than nearly half of other U.S. companies. Despite this, the company has shown solid past earnings growth and is anticipated to have future earnings growth that surpasses the market average, making its high P/E understandable to investors. Shareholders seem confident about its future prospects, suggesting the share price is unlikely to decline significantly soon.
Universal Beteiligungs und Servicegesellschaft mbH Decreases Position in Option Care Health, Inc. $OPCH
Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in Option Care Health (NASDAQ:OPCH) by 22.7% in the third quarter of 2025, selling 45,565 shares and retaining ownership of 155,344 shares. This institutional investor now holds approximately 0.10% of the company, valued at $4.31 million. Concurrently, an insider, Director Harry M. Jansen Kraemer Jr., increased his holdings by over 10% through a purchase of 38,000 shares in November.
Strs Ohio Grows Stock Holdings in Option Care Health, Inc. $OPCH
Strs Ohio significantly increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 145.9% during the third quarter, bringing its total holdings to 48,200 shares valued at $1,338,000. Other institutional investors also adjusted their positions in the company, which currently has a market capitalization of $5.61 billion and an average analyst rating of "Moderate Buy." Recent analyst ratings have set an average price target of $37.46, with some analysts upgrading the stock and raising their price targets.
Compass Wealth Management LLC Sells 182,440 Shares of Option Care Health, Inc. $OPCH
Compass Wealth Management LLC significantly reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 98.7%, selling 182,440 shares. Concurrently, Director Harry M. Jansen Kraemer Jr. increased his holdings by purchasing 38,000 shares for over $987,000, bringing his total to 413,390 shares. Analysts generally maintain a "Moderate Buy" rating for OPCH, with a consensus price target of $37.46, following several target increases.
Why Option Care (OPCH) Could Beat Earnings Estimates Again
Option Care (OPCH) is poised to beat earnings estimates again, driven by a strong history of surpassing expectations and positive analyst sentiment. The company has a Zacks Earnings ESP of +1.54% and a Zacks Rank #3 (Hold), indicating a high probability of a positive surprise for its upcoming earnings report expected on February 24, 2026. This analysis suggests investors should consider OPCH due to these favorable metrics.
Massachusetts Financial Services Co. MA Buys 33,019 Shares of Option Care Health, Inc. $OPCH
Massachusetts Financial Services Co. MA increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 2.7%, acquiring an additional 33,019 shares, bringing its total ownership to 1,244,321 shares valued at approximately $34.54 million. This move is complemented by continued insider confidence, as evidenced by Director Harry M. Jansen Kraemer Jr.'s purchase of 38,000 shares. Option Care Health, currently trading near its 12-month high with a market cap of $5.81 billion, holds a consensus "Moderate Buy" analyst rating and a target price of $37.50.
Option Care Health stock reaches all-time high of 36.63 USD
Option Care Health's stock achieved an all-time high of $36.63, reflecting a 21.73% increase over the past year and a 13.78% gain year-to-date. The company boasts a strong financial health score with a market capitalization of $5.81 billion and revenue of $5.53 billion, along with 15.79% revenue growth. Analysts remain bullish, with several firms raising price targets following positive preliminary Q4 financial results and reaffirming "Buy" ratings.
Option Care Health stock reaches all-time high of 36.63 USD
Option Care Health Inc. (OPCH) has achieved an all-time high stock price of $36.63, reflecting a 21.73% increase over the past year and a 13.78% gain year-to-date. The company boasts strong financials with a $5.81 billion market cap and $5.53 billion revenue, alongside impressive 15.79% revenue growth and bullish analyst ratings. Recent preliminary Q4 results show anticipated revenue between $1.46 billion and $1.47 billion, reinforcing investor confidence and potential for continued market success.
Option Care Health stock reaches all-time high of 36.63 USD
Option Care Health Inc. (OPCH) has achieved an all-time high stock price of $36.63, reflecting a 21.73% increase over the past year and a 13.78% gain year-to-date. The company boasts a strong financial health score from InvestingPro, with a market capitalization of $5.81 billion and revenue of $5.53 billion. Analysts remain bullish, with several firms raising price targets following positive preliminary Q4 financial results and reaffirming buy ratings.
Option Care Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call
Option Care Health Inc. (NASDAQ: OPCH) will release its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before market open. The company's management will host a conference call on the same day at 8:30 a.m. E.T. to discuss the results, with registration and webcast details provided for interested participants.
Option Care Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call
Option Care Health Inc. (NASDAQ: OPCH) announced it will release its fourth-quarter and full-year 2025 financial results on Tuesday, February 24, 2026, before the market opens. The company will also host a conference call at 8:30 a.m. E.T. on the same day to discuss the results. Participants can pre-register for the call or access a live audio webcast on their investor relations website.
Option Care Health (NASDAQ:OPCH) Hits New 52-Week High - Should You Buy?
Option Care Health (NASDAQ:OPCH) recently reached a new 52-week high of $36.34, closing at $36.41. The company has a "Moderate Buy" consensus rating from analysts with an average price target of $37.50, and insiders, including director Harry M. Jansen Kraemer Jr., have been buying shares. Institutional investors hold a significant portion of the stock.
Live Oak Investment Partners Makes New $913,000 Investment in Option Care Health, Inc. $OPCH
Live Oak Investment Partners has made a new investment of $913,000 in Option Care Health (NASDAQ:OPCH), acquiring 32,883 shares in the third quarter. Director Harry M. Jansen Kraemer Jr. also increased his stake by purchasing 38,000 shares for $987,240. Analysts have a "Moderate Buy" consensus rating for the stock, with an average price target of $37.50, and several have recently raised their price targets into the mid-$30s.
Assessing Option Care Health (OPCH) Valuation After New 2025 Outlook And US$1b Buyback Expansion
Option Care Health (OPCH) has released preliminary 2025 revenue and earnings figures, fresh 2026 guidance, and expanded its share buyback program to US$1 billion. The stock has seen strong momentum with significant returns over 90 days, 1 year, and 5 years. Analysts currently view the stock as undervalued, with a fair value of US$36.45 compared to its last close of US$36.11, despite a range of price targets.
Option Care Health (OPCH) Is Up 9.8% After Doubling Its Share Buyback Authorization to $1 Billion
Option Care Health (OPCH) has seen its stock rise by 9.8% following the announcement that its Board doubled the share repurchase authorization to $1 billion. This move reinforces management's confidence in the company's financial health, building on over 6% of shares already repurchased in 2025. The company also issued 2026 guidance, projecting net revenue between $5.8 billion and $6.0 billion, further signaling its commitment to capital return and growth.
Option Care Health stock hits 52-week high at $35.53
Option Care Health Inc. (OPCH) recently hit a 52-week high of $35.53, reflecting a 22.91% increase in value over the past year and a 13.27% return in the last six months. The company's strong performance, supported by strategic initiatives like a share buyback program and a "GREAT" financial health score from InvestingPro, suggests it is slightly undervalued. Several research firms, including Jefferies, Truist Securities, and Stephens, have reiterated Buy or Overweight ratings with increased price targets, citing robust financial results and strategic positioning.
Option Care Health stock hits 52-week high at $35.53 By Investing.com
Option Care Health (OPCH) stock recently reached a new 52-week high of $35.53, marking a 22.91% increase over the past year and a 13.27% return in the last six months. The company, valued at $5.62 billion, is considered slightly undervalued according to InvestingPro's financial health score. This milestone follows strong preliminary fourth-quarter results and positive outlooks from several research firms, including Jefferies, Truist Securities, Citizens, and Stephens, which have raised their price targets and reiterated favorable ratings for the company.
Option Care Health stock hits 52-week high at $35.53 By Investing.com
Option Care Health Inc. (OPCH) recently hit a 52-week high of $35.53, reflecting a 22.91% increase over the past year. The healthcare services company, valued at $5.62 billion, has garnered investor confidence due to strong market performance, strategic initiatives including a share buyback program, and positive analyst ratings. Recent preliminary Q4 revenue figures and raised price targets from several firms underscore the company's robust financial health and promising outlook.
Option Care (OPCH) Runs to Near Record on Preliminary FY25 Results
Option Care Health Inc. (NASDAQ:OPCH) saw its stock nearly hit a 52-week high after announcing higher preliminary net revenues for full-year 2025. The company expects net revenues between $5.645 billion and $5.655 billion, and adjusted diluted EPS in the range of $1.72 to $1.76. Official results and 2026 guidance are anticipated next month.
Why Option Care Health (OPCH) Stock Is Up Today
Option Care Health (NASDAQ:OPCH) shares rose significantly after the company announced it was doubling its share repurchase authorization to $1.0 billion and released preliminary 2025 results. Despite 2026 revenue guidance slightly missing some analyst estimates, investor sentiment was positive due to the substantial buyback and raised price targets from analysts at Citizens and Morgan Stanley. This positive news contrasts with a prior drop related to a less impressive full-year outlook and weaker cash flow in Q3.
Why Option Care Health (OPCH) Stock Is Up Today
Option Care Health (OPCH) stock rose by 8.9% after the company doubled its share repurchase authorization to $1.0 billion and released preliminary 2025 results. Despite a 2026 revenue forecast that slightly missed analyst estimates, the significant buyback and positive analyst price target raises from Citizens and Morgan Stanley buoyed investor sentiment. The update indicates that the market views this news as meaningful for the relatively stable stock.
Option Care Health reporta receita de US$ 1,46-1,47 bilhões no 4º trimestre
Option Care Health (NASDAQ:OPCH) divulgou resultados financeiros preliminares não auditados para o quarto trimestre e ano completo de 2025, além de projeções para 2026. A empresa espera uma receita líquida no quarto trimestre entre US$ 1,46 bilhão e US$ 1,47 bilhão, e para o ano de 2025, entre US$ 5,645 bilhões e US$ 5,655 bilhões. A Option Care Health também anunciou uma expansão de seu programa de recompra de ações para US$ 1,0 bilhão e analistas indicam que a empresa pode estar ligeiramente subvalorizada.
Jefferies raises Option Care Health stock price target to $37 on strong Q4
Jefferies has increased its price target for Option Care Health (NASDAQ:OPCH) to $37.00 from $32.00, maintaining a Buy rating, following the company's strong preliminary fourth-quarter results and share buyback activity. Other firms like Truist Securities, Citizens, and BofA Securities have also raised their price targets or reiterated Buy ratings, reflecting a positive outlook on the company's financial performance and strategic position. The company's Q4 pre-release showed revenue and EPS strength, along with initial 2026 guidance largely in line with expectations.
Option Care Health's (OPCH) "Market Outperform" Rating Reaffirmed at Citizens Jmp
Citizens Jmp has reiterated a "Market Outperform" rating for Option Care Health (OPCH) and raised its price target to $38.00, suggesting a 9.0% upside. This aligns with a moderate buy consensus from other analysts, with an average target price of $36.45. Insider buying by Director Harry M. Jansen Kraemer, Jr. and significant institutional ownership further underscore confidence in the company.
Is Option Care’s Expanded US$1 Billion Buyback Altering The Investment Case For Option Care Health (OPCH)?
Option Care Health recently announced preliminary Q4 and full-year 2025 results, alongside initial 2026 revenue guidance of US$5.8 billion to US$6.0 billion, and doubled its share repurchase authorization to US$1.0 billion. This strategic move signals management's confidence in the company's business model and emphasizes capital returns as a key use of cash. The expanded buyback authorization is expected to significantly impact Option Care Health's investment narrative and risk-reward profile, although near-term focus remains on execution in higher acuity therapies and managing reimbursement and therapy mix risks.
Option Care Health: Resilient Core Growth, Structural Tailwinds, and Capital Allocation Support Buy Rating
Bank of America Securities analyst Joanna Gajuk reiterated a Buy rating on Option Care Health (OPCH) with a price target of $40.00, citing the company's resilient core growth and structural tailwinds despite some impact from Stelara. The improved visibility in future growth and the board's expanded share repurchase authorization signal strong underlying business and management's confidence, further supporting the positive outlook for the stock. Another report by TipRanks – DeepSeek also reiterated a Buy rating with a $35.00 price target.
Option Care Health (NASDAQ:OPCH) Releases Q4 2025 Earnings Guidance
Option Care Health (NASDAQ:OPCH) has updated its Q4 2025 earnings guidance, projecting an EPS of $0.460–$0.490, exceeding the consensus estimate of $0.440, and revenue guidance of $1.5 billion. The company also raised its FY2025 EPS guidance to $1.720–$1.760. Wall Street analysts maintain a "Moderate Buy" rating with an average target price of $36.27, and insider activity shows a director purchasing 38,000 shares, increasing his stake.
Option Care Health reports Q4 revenue of $1.46-1.47 billion By Investing.com
Option Care Health announced preliminary unaudited financial results for Q4 and full year 2025, projecting Q4 net revenue between $1.46 billion and $1.47 billion, and full year net revenue of $5.645 billion to $5.655 billion. The company also provided 2026 guidance, expecting net revenue between $5.8 billion and $6.0 billion, and expanded its share repurchase program authorization from $500 million to $1.0 billion. Analysts, despite varying price targets, generally view the company favorably, noting its strong market position and aggressive share buybacks.
Option Care Health Inc - Q4 2025 Net Revenue Expected At $1.46 Billion-$1.47 Billion - SEC Filing
Option Care Health Inc. (OPCH) has announced its expected net revenue for Q4 2025 to be between $1.46 billion and $1.47 billion, according to an SEC filing. This information was released via Reuters news and is based on the company's latest financial disclosures. The article primarily highlights this revenue projection without further detailed text.
Option Care Health, a home infusion leader, expects up to $6B next year
Option Care Health reported preliminary unaudited results for Q4 and full year 2025, and provided preliminary financial guidance for full year 2026, with net revenue projected between $5.8 billion and $6.0 billion. The company's board also expanded its share repurchase authorization to $1.0 billion, following $307 million in repurchases during 2025. Despite positive revenue and EBITDA expectations, cash flow from operations for 2025 is expected to be below $320 million.
Summit Creek Advisors LLC Sells 35,730 Shares of Option Care Health, Inc. $OPCH
Summit Creek Advisors LLC reduced its stake in Option Care Health (NASDAQ:OPCH) by 6.9% in the third quarter, selling 35,730 shares and retaining 485,603 shares valued at approximately $13.48 million. Despite this, other institutional investors increased their holdings, and an insider, Director Harry M. Jansen Kraemer Jr., bought 38,000 shares, signaling confidence. Analysts maintain a "Moderate Buy" rating with an average price target of $36.27.
Option Care Health (NASDAQ:OPCH) Upgraded to "Buy" at Wall Street Zen
Option Care Health (NASDAQ:OPCH) was upgraded to a "Buy" rating by Wall Street Zen, signaling improved analyst sentiment. The company has a "Moderate Buy" consensus rating with a target price of $36.27. Recent insider buying by Director Harry M. Jansen Kraemer Jr. and significant institutional ownership highlight confidence in the stock.
Is Option Care Health (NASDAQ:OPCH) A Risky Investment?
Option Care Health (NASDAQ:OPCH) uses debt in its business, with net debt at approximately US$845.5 million as of September 2025. While the company has liabilities exceeding cash and near-term receivables, its market capitalization of US$5.11 billion suggests it could raise capital if needed. Option Care Health's debt-to-EBITDA ratio is 2.1, and its EBIT covered interest expenses 6.6 times last year, indicating a manageable debt load, further supported by strong free cash flow generation.
Option Care Health, Inc.'s (NASDAQ:OPCH) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
This article discusses Option Care Health, Inc.'s stock performance, which has shown an upward trend. The analysis suggests that the company's strong financial health, indicated by its Return on Equity and net income growth, could be a key factor influencing this market behavior. The article aims to explore the relationship between the company's financials and its stock's recent performance.
Is Option Care Health (NASDAQ:OPCH) A Risky Investment?
Option Care Health (NASDAQ:OPCH) uses debt in its business, with net debt of US$845.5m as of September 2025. While its liabilities exceed cash and near-term receivables, its market capitalization of US$5.11b suggests it could raise capital if needed. The company's debt-to-EBITDA ratio is 2.1x, and EBIT covers interest expense 6.6 times, indicating a manageable debt load, further supported by strong free cash flow generation.
Is Option Care Health (NASDAQ:OPCH) A Risky Investment?
This article analyzes Option Care Health's (NASDAQ:OPCH) debt levels to assess its investment risk. While the company uses debt, its net debt to EBITDA ratio is reasonable, and its EBIT comfortably covers interest expenses. The analysis concludes that Option Care Health manages its debt sensibly, positioning it to generate returns for shareholders despite some inherent risk.
BofA Securities Raises Price Target on Option Care Health to $40 From $35, Maintains Buy Rating
BofA Securities has increased its price target for Option Care Health (OPCH) to $40, up from the previous $35, while reiterating a Buy rating on the stock. This adjustment reflects continued analyst confidence in the company's future performance. The article also notes other recent analyst actions, including Deutsche Bank raising its price target to $36, and provides a company profile highlighting Option Care Health's role as a leading provider of home and alternate site infusion services.
Option Care Health, Inc. (OPCH) Stock Analysis: A 13% Upside Potential Amid Robust Healthcare Growth
Option Care Health, Inc. (OPCH) is presented as a strong player in the healthcare sector, specifically in home and alternate site infusion services, with a market cap of $5.23 billion and a stock price of $32.24. The company shows robust financial health, evidenced by a 17.11 forward P/E ratio, 12.20% revenue growth, and a 15.03% return on equity. With strong analyst confidence and an average target price of $36.45, OPCH demonstrates a potential upside of approximately 13.07%, despite its RSI indicating an overbought condition.
Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Option Care Health, Inc. (NASDAQ:OPCH) has received a "Moderate Buy" consensus recommendation from fourteen brokerages, with an average one-year price target of $36.27. Insider activity shows Director Harry M. Jansen Kraemer, Jr. purchasing 38,000 shares in November, increasing his stake by over 10%. The company has high institutional ownership at 98.05% and a market capitalization of $5.12 billion.
